• Rallybio's one-for-two reverse stock split is expected to take effect at 4:01 p.m. Eastern Time on November 20, 2026.
• The corrected timing replaces 12:01 a.m. Eastern Time incorrectly reported in the November 10, 2026, press release.
• Shares are expected to begin trading on a split-adjusted basis on November 23, 2026.
• The reverse split is tied to the proposed merger with Avenzo Therapeutics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202611110815BIZWIRE_USPR_____20261111_BW962710) on November 11, 2026, and is solely responsible for the information contained therein.